Valirx Share Discussion Threads

[wulber] 15/8/2023 17:23

Frustrating at the moment, up 0.5p then down!

[porky9] 15/8/2023 10:12

@JasonPugh
Ok - accept your point but would argue it’s a fine line. Suzy only has to report via RNS a change that could have an impact on the share price. IF she doesn’t ask THX the question nothing to report. Unless THX inform her they are no longer proceeding she doesn’t have to report anything, so this matter can be kicked into the long grass until ultimately she has to address it

[jasonpugh] 15/8/2023 08:51

@porky. I agree. However when you say suzy would prefer to not comment on 201 this would violate nomad rules on disclosure…..
this in my view she has already been doing.
Very sinister if you ask me.
My fiancee teaches trauma bio resonance and psychological training and behavioural dynamics(shes a pure genius) . When i showed her the videos of suzy. Especially going red in the face when discussing 201 she said instantly that she felt suzy was hiding something. A view shared by many im afraid. And she didn’t like kevin cox either. She said he tried to manipulate by coercion the presentation.

Oh and did you notice how msny rns came out pre agm?
Amazing how valirx can dig deep to keep control.
Oh and not to forget panu and other board members not buying and their ridiculous excuses..,
Suzy. “What i do with my finances is i have to look after my family..”
Panu. “ not investing as lse chat room comments dictate i should!”
The financial guy. “ its very hard to find time or avwindow for board members to buy due to closed period”

What! 🫣

[jasonpugh] 14/8/2023 20:11

Dilys rns today was plastic. Susy knows theoromrx is not happening with 201. Investors have been misled by her and kevin cox. What will happen next…..
My view. Suzy will release rns saying unforeseen problems were encountered by Theoremrx and funding and unfortunately theoremrx have been unsuccessful at obtaining funding for 201. Accordingly we at valirx would like to repeat that the letter of intent was clearly stated as not a guarantee of success in the rns previous.(rns dated june 8th 2023 para 2 “the loi and proposed licence agreement (as refereed to in the announcement of nov 2nd 2021 ) remain non -binding and there is no guarantee that this license agreement will be executed or that it will GENERATE MATERIAL REVENUES within the expected timeframe “””;”OR AT ALL””221;””

Or at all. To all shareholders and potential shareholders. Focus on those last words “ OR AT ALL”
Question… is it worth investing in valirx after that comment?

You see. Suzy knows her jobs safe by this back door get out clause. Or is it. DYOR 😳

[jasonpugh] 14/8/2023 12:11

Nick slater following porky (@porky9here) on twitter. Lol 😳🫣

[wulber] 14/8/2023 11:44

Good Luck Porky ?

[porky9] 14/8/2023 11:37

@Wulber
What money in the bank????? (a three month lab contract of no specified value?)

Lights out turn of the year. December is a dead month to raise capital with so many away, you cant leave it to the death to raise funds and what client of value will enter into high contract values with a lab that doesn't officially launch until September that has insufficient funds in place???

They need to get the placing done now but the question is if it will get supported or not and if they can pull it off what the discount will be.

Good luck to them, the market conditions are tough. I stand by a 3.5p placing.

[porky9] 14/8/2023 11:30

Oh please....
Its simply another micro lab near their rented lab in the same block at Medicity



Well you can dream all you like about "contract values being confidential" but H1 to end of June will be out shortly, last year 31/8 unless they can hold it back and it will confirm ZERO revenue again and massively increased cash burn as forecast. The placing confirmation will follow it IF they can secure support.

They will be holding the placing talks possibly as i write, it needs sorting shortly, and ideally they could do with more fluff news to pump the share price a bit to get the placing away at discount - watch this space.

And don't try and paint it that the share price is some amazingly low price, its bloody not, its VERY expensive at this 6-7p level. I would remind you that the market cap in April 21 correlates to a share price of just over 2p. I would argue that the business is in worse shape now than it was back then, for one thing the Cash burn is now back to those levels.

Lets see IF they can secure funding support or not, that's the challenge they now face.

[wulber] 14/8/2023 11:24

So monies in bank until early-mid 2024 (no placing Porky) and self financing from the lab shortly in addition to undisclosed revenues already towards cash burn.

[livedata21] 14/8/2023 10:19

7p clearly the 52wk low. Already revenue generating - contract values are not released as it is confidential.

[412069] 14/8/2023 09:53

Keep dreaming stalker boy.

[porky9] 14/8/2023 09:07

Very good effort to pump the share price a bit to help get the placement over the line at discount, if they can get the share price to 8 or 9p, stronger chance of getting the placement in at 4p or maybe 5p

Be interesting to see how investors react, what you won't see is an RNS that says £x is landing in our account this month from business transacted. BUT it will really help the ramping squad on LSE

[francoismyname] 14/8/2023 08:15

Reads “More Jam tomorrow “ yet again to me.

Read dozens of RNS’s like that from Val over the last 12 years.,

[criticalthinker1] 14/8/2023 07:33

Interesting RNS. Sareum are continuing to undertake Translational studies with SDC 1802. This is imo due to be ramped up with the progress of SDC 1801 p1a trials data.

Thos would dovetail very well with Sareums recent patent approvals.

Just joining some dots that may or may not be there but given our past history and affiliation and Sareums forward momentum after having to supercede the MHRA debacle we have in Blighty.....this would be a logical step forward. Very timely!

Good luck all in both companies

Steadydanny

[porky9] 14/8/2023 05:44

@Dope007
Well they have had a bloody good run at it frankly
15 raises, three 125:1 consolidations, 5 raises under Suzy and 6th raise anytime soon.
If anyone can raise cash they can.

Although, there can’t be that many private investors left that haven’t been offered discounted shares. I mean they have rinsed the clients of S P Angel, Cenkos and the last two placing at Turner Pope one in the July 22 and the follow on in Jan 23, where do you go from there?

This next placing end of month or early Sept is going to take some skill to convince private investors to dig deep yet again. As I say I’m 50/50 IF they will get support at all this time, simply because markets are still brutal and this sector under continued pressure, IF they can convince investors to back them again for extended working capital then it’s going to need to include a dam good discount for sure as I see it. Also because markets have been depressed and many portfolios down, there is even less appetite to move cash to more riskier AIM plays.

Just a waiting game now to see if they can pull it off or not

[dope007] 13/8/2023 19:24

The only bull argument is "they have funds" They always run out and when they can't dilute anymore they go pop.

[wulber] 11/8/2023 21:03

Jasonpugh? Are you invested, what the hell are you doing causing are invested company with FCA issues? Are you crazy?Get a grip man

[porky9] 11/8/2023 15:16

Very good precis by poster @Borsaci06 over on LSE in response to the usual ramping club garbage posts, although the poster is wasting their time trying to share information, chief ramper PM2022 is already on the case LOL:-

I would also add that CROs tend to be valued as a multiple of EBITDA. Typical valuations range from 5x (for smaller, slower growing, riskier CROs) up to 14x (highly attractive desired assets)

So VAL would need to deliver on average at least £1m EBITDA or so to warrant the current eye watering valuation. They have to turn a loss of £2.4m to an EBITDA of £1m plus and the rampers think this will be done in a flash.

This is going to take so much cash in sales and marketing from here, i'm genuinely 50/50 if they will secure the support to get the placing done at all. My 3.5p placing estimate could be well of, this could be similar to APTA who are with the same brokers in which case we are talking 1.5p to 2p placing here.

[jasonpugh] 11/8/2023 08:00

@ porky. Not only her emails twitter but also LinkedIn conversations regarding slater and mark treharne. Phone the number for yourself and if you are prepared to wait to talk to him you will be pleasantly surprised.

[porky9] 11/8/2023 07:31

@JasonPugh
? Just read your last comment, thinking you might have totally lost the plot? Don’t understand what you are trying to suggest? Your end goal with the FCA?
Are you saying that the business has in some way been misleading investors by not declaring the full facts of 201 and using social media with the “unconcerned” comments to encourage buying when they already know the 201 deal is dead? Trying to understand your chain of thought?

I genuinely don’t think the board have done anything illegal, inexperience of corporate matters at times and probably believe everything they are told by THX but not deliberate non disclosure.

In any event let’s face it even if they were deliberately not disclosing information, they wouldn’t be the first on the AIM. Form an orderly line please... further, the FCA are next to useless and take many many years to do anything at the best of times, even when facts of a stitch up are black and white and in their face.

At some point VAL will need to draw a line under 201 with THX in my opinion but probably just leaving until THX actually say, no we can’t raise we are no longer interested, rather than pushing the matter. it’s far better on the back burner as a future maybe, than the board confirming they made the wrong call or circumstances have changed and the deal is dead. We will know in due course anyhow.

[jasonpugh] 10/8/2023 13:23

Contacted FCA on 0800 111 6768. and boy what a wait. 25 mins to talk to someone. Anyway phil said that there have been numerous complaints about the valirx board from shareholders about disclosure and social media snd insider trading. The 201 debacle especially has been a recent focus especially through rns and suzy dily social media. He wouldn’t comment further on individual complaints but i was assured that the 8 week rule for companies to answer complaints was not violated.
Ongoing. Watch this space 👍